je.st
news
Tag: impairment
NL Industries: A Fascinating Case, But Not Enough Value And Risk Of 100% Capital Impairment
2015-09-14 10:06:58| Chemicals - Topix.net
Harold Simmons raided NL Industries in the '80s, took control, and morphed it into the conglomerate it is today. Simmons passed away in 2013 and his family now controls the company.
BHP Billiton takes $2bn impairment charge on US shale assets
2015-07-16 01:00:00| Hydrocarbons Technology
BHP Billiton has taken $2bn impairment charges on its US onshore petroleum assets after one of its Texas gas field became more costly to develop.
Tags: charge
takes
assets
impairment
SoftBank says will not consolidate Sprint's $2 billion impairment charge
2015-02-05 19:56:19| Telecom - Topix.net
Japan's SoftBank Corp said on Thursday it would not recognise in its consolidated financial statements the $2.1 billion impairment charge made by its majority-owned U.S. telecoms network operator Sprint Corp , because of differing accounting standards. Earlier Sprint said the charge included a $1.9 billion reduction associated with the Sprint trade name and about $200 million reduction in the carrying value of its wireline network assets.
Tags: charge
billion
impairment
consolidate
ShawCor Announces Expected Impairment Charge
2014-12-23 03:32:54| Chemicals - Topix.net
ShawCor Ltd. announced today that it expects to incur an after tax impairment charge of up to approximately $80 million, relating to the goodwill and intangible assets of the Socotherm Gulf of Mexico coating facility in Channelview, Texas and the carrying value of Socotherm's 50% joint venture interest in Venezuela. The charge results from recently conducted annual impairment testing under IFRS of the carrying value of ShawCor's long lived assets.
Tags: charge
expected
announces
impairment
Age, Renal Impairment and Depth of Response Analyses of the FirstTM...
2014-12-08 04:49:40| Biotech - Topix.net
Celgene Corporation today announced that results were presented from multiple post-hoc analyses of its pivotal phase III FIRSTTM trial, comparing continuous REVLIMIDA plus low-dose dexamethasone to a fixed duration of 18 cycles of Rd or 12 cycles of melphalan, prednisone and thalidomide for the treatment of newly diagnosed, transplant-ineligible multiple myeloma. The studies were presented during the 56th American Society of Hematology annual meeting.